CureMatch Appoints Visionary Leader, Ally Perlina, as Chief Science Officer
Leader brings two decades of industry experience in precision medicine, pharmaceutical and translational science to focus on personalized cancer treatments
SAN DIEGO, CALIFORNIA, UNITED STATES, December 15, 2020 /EINPresswire.com/ — CureMatch, Inc., a leader in precision medicine digital solutions, has expanded its leadership team naming Ally Perlina, Ph.D., as chief science officer (CSO). In this role, she will innovate and advance the CureMatch decision support system and .expand the company’s development of additional AI products for precision medicine and digital health.
“We are thrilled to have Ally join our executive team,” said Navid Alipour, chief executive officer of CureMatch. “Her cutting-edge expertise….Read More